2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
2046
Neoplasms
1458
Carcinoma, Non-Small-Cell Lung
1362
Prostatic Neoplasms
1106
Multiple Myeloma
872
Leukemia, Myeloid, Acute
770
Colorectal Neoplasms
712
Neoplasm Metastasis
704
Lung Neoplasms
697
Melanoma
687
Lymphoma
666
Leukemia
595
Lymphoma, Non-Hodgkin
593
Leukemia, Lymphocytic, Chronic, B-Cell
535
Ovarian Neoplasms
532
Pancreatic Neoplasms
500
Precursor Cell Lymphoblastic Leukemia-Lymphoma
485
Recurrence
474
Myelodysplastic Syndromes
424
Lymphoma, Follicular
418
Carcinoma, Renal Cell
411
Head and Neck Neoplasms
408
Glioblastoma
380
Lymphoma, Large B-Cell, Diffuse
379
Brain Neoplasms
375
Hodgkin Disease
354
Carcinoma, Hepatocellular
333
Squamous Cell Carcinoma of Head and Neck
326
Lymphoma, Mantle-Cell
306
Sarcoma
286
Interventions
Temozolomide
1
Irinotecan
1
FANG vaccine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has results
×
Rare Diseases
×
Clear all
NCT06397443
2025-03-21
PaS
Istituto Ortopedico Rizzoli
Phase NA
Completed
8 enrolled
28 charts
NCT03495921
2023-04-26
VITA
Gradalis, Inc.
Phase 3
Terminated
32 enrolled
13 charts